ASH Clinical News: FDA Marketing Approval for Polycythemia Vera Test Kit

The U.S. Food and Drug Administration (FDA) has granted marketing approval to the ipsogen JAK2 RGQ PCR Kit – the first FDA-authorized in vitro test for the evaluation of suspected polycythemia vera (PV). The testing kit detects mutations in the JAK2 gene in patients with suspected PV by sequencing data from DNA extracted from EDTA whole blood.

No comments have been posted yet.